Evidence map›Paper›PMID 42586724›Full record

ArticleBMJ open2026

Surveillance for neurodevelopmental impairment (NDI) in high-risk neonates: a cohort study at a tertiary care hospital in Pakistan.

Sidra Kaleem Jafri, Nadia Mazhar, Adnan Mirza, Tarab Zehra, Zohra Shams, Kinza Naseem Elahi, Jai K Das, Moghira Iqbal Siddiqui, Shelina Bhamani, Haroon Tayyab and 2 more

Abstract read
In one paragraph

Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sidra Kaleem JafriDepartment of Paediatrics and Child Health, The Aga Khan University, Karachi, Pakistan sidra.kaleem@aku.edu.ORCID http://orcid.org/0000-0002-3104-6891
Nadia MazharDepartment of Paediatrics and Child Health, The Aga Khan University, Karachi, Pakistan.
Adnan MirzaDepartment of Paediatrics and Child Health, The Aga Khan University, Karachi, Pakistan.
Tarab ZehraDepartment of Paediatrics and Child Health, The Aga Khan University, Karachi, Pakistan.
Zohra ShamsDepartment of Paediatrics and Child Health, The Aga Khan University, Karachi, Pakistan.
Kinza Naseem ElahiDepartment of Paediatrics and Child Health, The Aga Khan University, Karachi, Pakistan.
Jai K DasDepartment of Paediatrics and Child Health, The Aga Khan University, Karachi, Pakistan.ORCID http://orcid.org/0000-0002-2966-7162
Moghira Iqbal SiddiquiDepartment of Surgery, The Aga Khan University, Karachi, Sindh, Pakistan.
Shelina BhamaniObstetrics & Gynecology, The Aga Khan University Hospital, Karachi, Sindh, Pakistan.ORCID http://orcid.org/0000-0001-8308-0947
Haroon TayyabOphthalmology and Visual Sciences, The Aga Khan University Hospital Main Campus Karachi, Karachi, Pakistan.
Arjumand RizviDepartment of Paediatrics and Child Health, The Aga Khan University, Karachi, Pakistan.
Shahnaz IbrahimDepartment of Paediatrics and Child Health, The Aga Khan University, Karachi, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHigh-risk neonates are at greater risk for neurodevelopmental impairment (NDI) despite improved neonatal survival. In low-income and middle-income countries, including Pakistan, developmental trajectories across infancy and toddlerhood of high-risk neonates are not well studied, especially when the survival is improving.

methodsThis 2-year longitudinal cohort study was performed at the neonatal intensive care unit and Child Development and Rehabilitation Centre of Aga Khan University Hospital in Pakistan. High-risk neonates who met predefined clinical criteria were enrolled and evaluated at 6 months, 12 months and 24 months of age using the Bayley Scales of Infant and Toddler Development, Fourth Edition. NDI has been defined as moderate-severe hearing or visual impairment, cerebral palsy or global developmental delay (ie, ≥2 SD delay in ≥2 Bayley domains).

resultsOut of 369 eligible neonates, 198 of them had at least one assessment. NDI prevalence increased to 15.7% at 2 years compared with 8.2% at 6 months. Overall, language impairment showed the largest increase (2.6%-9.6%), while cognitive (5.2%-7.1%) and motor (5.2%-7.6%) impairments rose modestly.Placental abruption was linked to the risk of NDI in univariable analysis (HR=3.53, 95% CI 1.07 to 11.62). Low birth weight was associated with gross motor impairments (HR=2.90, p=0.01), while preterm birth also showed association with gross motor (HR=3.66, p=0.01) and receptive (HR=2.61, p=0.02) impairments. Receptive language impairment was related to pre-eclampsia (HR=2.06, 95% CI 1.17 to 3.64) and preterm premature rupture of membranes (HR=2.24, 95% CI 1.22 to 4.09). Expressive impairment was linked to prolonged hospital stay (HR=1.81, 95% CI 1.04 to 3.14) and lower household income (HR=2.07, 95% CI 1.24 to 3.45).

conclusionApproximately 15% of high-risk neonatal survivors showed evidence of NDI by 2 years of age with evolving language vulnerabilities and persistent gross motor risks. Overall, study findings highlight the need for urgent structured developmental surveillance and early child development intervention programmes for high-risk infants in Pakistan, as part of routine neonatal care pathways.

Indexed as

Developmental DisabilitiesNeurodevelopmental DisordersChild DevelopmentChild, PreschoolFemaleHumansInfantInfant, NewbornIntensive Care Units, NeonatalLongitudinal StudiesMaleNeurodevelopmentPakistanPrevalenceRisk FactorsTertiary Care CentersDevelopmental neurology & neurodisabilityInfantLongitudinal studiesPakistanRisk Factors

Identifiers

PMID42586724
PMCPMC13475371

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.